Correlation Between MEDIPOST and Bridge Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both MEDIPOST and Bridge Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MEDIPOST and Bridge Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MEDIPOST Co and Bridge Biotherapeutics, you can compare the effects of market volatilities on MEDIPOST and Bridge Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MEDIPOST with a short position of Bridge Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MEDIPOST and Bridge Biotherapeutics.

Diversification Opportunities for MEDIPOST and Bridge Biotherapeutics

-0.39

Correlation Coefficient

MEDIPOST  Bridge Biotherapeutics

Very good diversification

The 3 months correlation between MEDIPOST and Bridge is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding MEDIPOST Co and Bridge Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bridge Biotherapeutics and MEDIPOST is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MEDIPOST Co are associated (or correlated) with Bridge Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bridge Biotherapeutics has no effect on the direction of MEDIPOST i.e., MEDIPOST and Bridge Biotherapeutics go up and down completely randomly.

Pair Corralation between MEDIPOST and Bridge Biotherapeutics

Assuming the 90 days trading horizon MEDIPOST Co is expected to generate 0.8 times more return on investment than Bridge Biotherapeutics. However, MEDIPOST Co is 1.25 times less risky than Bridge Biotherapeutics. It trades about 0.21 of its potential returns per unit of risk. Bridge Biotherapeutics is currently generating about 0.03 per unit of risk. If you would invest  596,000  in MEDIPOST Co on September 24, 2024 and sell it today you would earn a total of  639,000  from holding MEDIPOST Co or generate 107.21% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

MEDIPOST Co  vs.  Bridge Biotherapeutics

MEDIPOST

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in MEDIPOST Co are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MEDIPOST sustained solid returns over the last few months and may actually be approaching a breakup point.

Bridge Biotherapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Bridge Biotherapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Bridge Biotherapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MEDIPOST and Bridge Biotherapeutics

The main advantage of trading using opposite MEDIPOST and Bridge Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MEDIPOST position performs unexpectedly, Bridge Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridge Biotherapeutics will offset losses from the drop in Bridge Biotherapeutics' long position.

The idea behind MEDIPOST Co and Bridge Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.